drugset / Trial / NCT05990543
Combination of Nelmastobart and Capecitabine Therapy in Metastatic Colorectal Cancer
NaSingle-groupOpen-labelTreatment
Summary
This is an open-label clinical trial aimed at evaluating the safety and efficacy of the combination treatment of nelmastobart with capecitabine in patients diagnosed with metastatic or recurrent colorectal cancer.
Timeline
- Start
- 2024-01-29
- Primary completion
- 2025-12-01
- Completion
- 2026-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Capecitabine | Small molecule | — | Oral |
| Subject | Nelmastobart | Monoclonal antibody | — | Intravenous |